Table of Contents

1 Study Coverage

• 1.1 Afinitor Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Afinitor Market Size Growth Rate by Product
  • 1.4.2 2.5mg
  • 1.4.3 5mg
  • 1.4.4 7mg
  • 1.4.5 10mg
• 1.5 Market by End User
  • 1.5.1 Global Afinitor Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Drugs Store
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Afinitor Market Size
  • 2.1.1 Global Afinitor Revenue 2014-2025
  • 2.1.2 Global Afinitor Sales 2014-2025
• 2.2 Afinitor Growth Rate by Regions
  • 2.2.1 Global Afinitor Sales by Regions
  • 2.2.2 Global Afinitor Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Afinitor Sales by Manufacturers
  • 3.1.1 Afinitor Sales by Manufacturers
  • 3.1.2 Afinitor Sales Market Share by Manufacturers
  • 3.1.3 Global Afinitor Market Concentration Ratio (CR5 and HHI)
• 3.2 Afinitor Revenue by Manufacturers
  • 3.2.1 Afinitor Revenue by Manufacturers (2014-2019)
  • 3.2.2 Afinitor Revenue Share by Manufacturers (2014-2019)
• 3.3 Afinitor Price by Manufacturers
• 3.4 Afinitor Manufacturing Base Distribution, Product Types
  • 3.4.1 Afinitor Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Afinitor Product Type
  • 3.4.3 Date of International Manufacturers Enter into Afinitor Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Afinitor Sales by Product
• 4.2 Global Afinitor Revenue by Product
• 4.3 Afinitor Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Afinitor Breakdown Data by End User

6 North America

• 6.1 North America Afinitor by Countries
  • 6.1.1 North America Afinitor Sales by Countries
  • 6.1.2 North America Afinitor Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Afinitor by Product
• 6.3 North America Afinitor by End User

7 Europe

• 7.1 Europe Afinitor by Countries
  • 7.1.1 Europe Afinitor Sales by Countries
  • 7.1.2 Europe Afinitor Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Afinitor by Product
• 7.3 Europe Afinitor by End User

8 Asia Pacific

• 8.1 Asia Pacific Afinitor by Countries
  • 8.1.1 Asia Pacific Afinitor Sales by Countries
  • 8.1.2 Asia Pacific Afinitor Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Afinitor by Product
• 8.3 Asia Pacific Afinitor by End User

9 Central & South America

• 9.1 Central & South America Afinitor by Countries
  • 9.1.1 Central & South America Afinitor Sales by Countries
  • 9.1.2 Central & South America Afinitor Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Afinitor by Product
• 9.3 Central & South America Afinitor by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Afinitor by Countries
  • 10.1.1 Middle East and Africa Afinitor Sales by Countries
  • 10.1.2 Middle East and Africa Afinitor Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Afinitor by Product
• 10.3 Middle East and Africa Afinitor by End User

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis Afinitor Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis Afinitor Products Offered
  • 11.1.5 Novartis Recent Development

12 Future Forecast

• 12.1 Afinitor Market Forecast by Regions
  • 12.1.1 Global Afinitor Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Afinitor Revenue Forecast by Regions 2019-2025
• 12.2 Afinitor Market Forecast by Product
  • 12.2.1 Global Afinitor Sales Forecast by Product 2019-2025
  • 12.2.2 Global Afinitor Revenue Forecast by Product 2019-2025
• 12.3 Afinitor Market Forecast by End User
• 12.4 North America Afinitor Forecast
• 12.5 Europe Afinitor Forecast
• 12.6 Asia Pacific Afinitor Forecast
• 12.7 Central & South America Afinitor Forecast
• 12.8 Middle East and Africa Afinitor Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Afinitor Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Afinitor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Afinitor market based on company, product type, end user and key regions.

This report studies the global market size of Afinitor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Afinitor in these regions.
This research report categorizes the global Afinitor market by top players/brands, region, type and end user. This report also studies the global Afinitor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis

Market size by Product
2.5mg
5mg
7mg
10mg
Market size by End User
Hospital
Drugs Store
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Afinitor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Afinitor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Afinitor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Afinitor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Afinitor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Afinitor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.